Cargando…

The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis

Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success i...

Descripción completa

Detalles Bibliográficos
Autores principales: Olaleye, Kehinde T, Oladunjoye, Adeolu O, Otuada, David, Anugwom, Gibson O, Basiru, Tajudeen O, Udeogu, Jennifer E, Opaleye-Enakhimion, Taiwo, Espiridion, Eduardo D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285755/
https://www.ncbi.nlm.nih.gov/pubmed/34277291
http://dx.doi.org/10.7759/cureus.15706
_version_ 1783723611388903424
author Olaleye, Kehinde T
Oladunjoye, Adeolu O
Otuada, David
Anugwom, Gibson O
Basiru, Tajudeen O
Udeogu, Jennifer E
Opaleye-Enakhimion, Taiwo
Espiridion, Eduardo D
author_facet Olaleye, Kehinde T
Oladunjoye, Adeolu O
Otuada, David
Anugwom, Gibson O
Basiru, Tajudeen O
Udeogu, Jennifer E
Opaleye-Enakhimion, Taiwo
Espiridion, Eduardo D
author_sort Olaleye, Kehinde T
collection PubMed
description Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success in management. This case report presents a 25-year-old African American female who presented to the emergency room with nervousness, sweating, insomnia, and visual and auditory hallucinations. She was treated symptomatically for anxiety but returned to the hospital after she continued to experience worsening symptoms. Her anxiety worsened, and she became more agitated, warranting an extensive workup, including magnetic resonance imaging (MRI) and electroencephalogram (EEG), which showed normal findings. She also had an anti-NMDA receptor antibodies titer done, which showed a positive titer result. She was treated with intravenous steroids, intravenous immunoglobulin G (IgG), plasma exchange, and rituximab, which did not improve her symptoms, and she was discharged home after a prolonged hospital stay. On follow-up visits, she reported worsening confusion, aggression, and suicidal behaviors. The patient was readmitted, during which she experienced catatonia and psychiatric symptoms, and her anti-NMDAR titer had increased to 1:1280. Further treatments with intravenous steroids, intravenous IgG, plasma exchange, and rituximab, including haloperidol and clonazepam, failed to improve her condition. However, her condition improved remarkably following treatment with 12 rounds of ECT. No randomized control trial has been done to demonstrate the effectiveness of ECT in the treatment of anti-NMDAR encephalitis despite various reports of the effectiveness of this treatment modality. This case report adds to the growing clinical evidence in support of the use of ECT in anti-NMDAR encephalitis patients with catatonia. ECT can be incorporated as standard protocol in the treatment of catatonia and associated psychiatric symptoms when managing a patient with anti-NMDAR encephalitis associated with catatonic features.
format Online
Article
Text
id pubmed-8285755
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-82857552021-07-17 The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis Olaleye, Kehinde T Oladunjoye, Adeolu O Otuada, David Anugwom, Gibson O Basiru, Tajudeen O Udeogu, Jennifer E Opaleye-Enakhimion, Taiwo Espiridion, Eduardo D Cureus Neurology Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success in management. This case report presents a 25-year-old African American female who presented to the emergency room with nervousness, sweating, insomnia, and visual and auditory hallucinations. She was treated symptomatically for anxiety but returned to the hospital after she continued to experience worsening symptoms. Her anxiety worsened, and she became more agitated, warranting an extensive workup, including magnetic resonance imaging (MRI) and electroencephalogram (EEG), which showed normal findings. She also had an anti-NMDA receptor antibodies titer done, which showed a positive titer result. She was treated with intravenous steroids, intravenous immunoglobulin G (IgG), plasma exchange, and rituximab, which did not improve her symptoms, and she was discharged home after a prolonged hospital stay. On follow-up visits, she reported worsening confusion, aggression, and suicidal behaviors. The patient was readmitted, during which she experienced catatonia and psychiatric symptoms, and her anti-NMDAR titer had increased to 1:1280. Further treatments with intravenous steroids, intravenous IgG, plasma exchange, and rituximab, including haloperidol and clonazepam, failed to improve her condition. However, her condition improved remarkably following treatment with 12 rounds of ECT. No randomized control trial has been done to demonstrate the effectiveness of ECT in the treatment of anti-NMDAR encephalitis despite various reports of the effectiveness of this treatment modality. This case report adds to the growing clinical evidence in support of the use of ECT in anti-NMDAR encephalitis patients with catatonia. ECT can be incorporated as standard protocol in the treatment of catatonia and associated psychiatric symptoms when managing a patient with anti-NMDAR encephalitis associated with catatonic features. Cureus 2021-06-17 /pmc/articles/PMC8285755/ /pubmed/34277291 http://dx.doi.org/10.7759/cureus.15706 Text en Copyright © 2021, Olaleye et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Olaleye, Kehinde T
Oladunjoye, Adeolu O
Otuada, David
Anugwom, Gibson O
Basiru, Tajudeen O
Udeogu, Jennifer E
Opaleye-Enakhimion, Taiwo
Espiridion, Eduardo D
The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title_full The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title_fullStr The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title_full_unstemmed The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title_short The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
title_sort effectiveness of electroconvulsive therapy on catatonia in a case of anti-n-methyl-d-aspartate (anti-nmda) receptor encephalitis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285755/
https://www.ncbi.nlm.nih.gov/pubmed/34277291
http://dx.doi.org/10.7759/cureus.15706
work_keys_str_mv AT olaleyekehindet theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT oladunjoyeadeoluo theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT otuadadavid theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT anugwomgibsono theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT basirutajudeeno theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT udeogujennifere theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT opaleyeenakhimiontaiwo theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT espiridioneduardod theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT olaleyekehindet effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT oladunjoyeadeoluo effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT otuadadavid effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT anugwomgibsono effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT basirutajudeeno effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT udeogujennifere effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT opaleyeenakhimiontaiwo effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis
AT espiridioneduardod effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis